Globe Life stock holds above USD 169 as earnings near

Published on 09/23/2026 at 11:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Globe Life stock closed at USD 169.43 on September 22, 2026, 11.5 percent below its yearly high. Q2 EPS reached USD 3.61.

Modernes Versicherungsbüro mit Beratern, die Familien zu Lebensversicherungen beraten — Globe Life Inc. zeigt ein modernes Lebensversicherungsbüro mit Beratern und Familien, ISIN US37959E1029, Illustration mit AI erstellt.

Globe Life Inc. (US37959E1029) closed at USD 169.43 on the New York Stock Exchange on September 22, 2026, down USD 2.73, or 1.59 percent, from the prior close. The next earnings date is estimated for October 21, 2026, according to the current market calendar.

Stock stays below yearly high

The September 22 close was 11.5 percent below the 52-week high of USD 191.55 and USD 41.58 above the 52-week low of USD 127.85. Globe Life's market capitalization was USD 13.021 billion, while volume reached 389,799 shares for the session.

The valuation gap gives the stock a measurable near-term reference point: the current price is closer to the yearly high than to the yearly low, but remains USD 22.12 below the average analyst target of USD 193.91. The average target implies a USD 24.48 difference from the September 22 close.

Quarterly earnings set the benchmark

Globe Life reported second-quarter fiscal 2026 revenue of USD 1.59 billion and earnings of USD 287.75 million. The company recorded actual second-quarter fiscal 2026 earnings per share of USD 3.61 against an estimate of USD 3.68, a shortfall of USD 0.07 per share.

The earnings comparison matters because the market is approaching the next scheduled reporting window with a clear numerical benchmark. The second-quarter EPS result came in 1.9 percent below the stated estimate, while the latest quote remains 14.4 percent below the average analyst target of USD 193.91.

Analyst target remains above price

Yahoo Finance lists a one-year average target of USD 193.91, with a high target of USD 225.00 and a low target of USD 166.00 as of September 22, 2026. The target range spans USD 59.00, showing that published expectations remain materially dispersed.

The same market overview records that Keefe, Bruyette and Woods maintained an Outperform rating on July 24, 2026, while lowering its price target from USD 192.00 to USD 190.00. That USD 2.00 reduction contrasts with the broader average target of USD 193.91 and provides a counterweight to the positive rating label.

Price and market data

Globe Life stock closed at USD 169.43 on the NYSE on September 22, 2026. The session's quoted daily change was negative 1.59 percent, with market capitalization at USD 13.021 billion and volume at 389,799 shares.